Hint mode is switched on Switch off

Ascendis Pharma, American depositary receipt (ADR)
ASND, US04351P1012

Add a stock to WL
Choose all Reset all
Ascendis Pharma, сountry — Denmark
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Ascendis Pharma A/S
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ASND
  • Placement
    28.01.2015
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    108 mln USD
  • Final placement price
    18 USD
  • Price change since placement date
    1,307.89%
  • By capitalization
    412.84 mln USD

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
2018
IV q eng
2017
IV q eng
Show all Hide

Indicators

News

06/03/2026 Ascendis Pharma A/S (NASDAQ:ASND) Price Target and Market Performance
03/03/2026 Ascendis Pharma A/S (NASDAQ:ASND) Gains Momentum with FDA Approval and Upgraded Rating
11/02/2026 Ascendis Pharma A/S (NASDAQ:ASND) Shows Promising Growth and Development in Biopharmaceuticals
06/11/2025 Ascendis Pharma A/S (NASDAQ:ASND) Sees Positive Analyst Sentiment and Growth Prospects
29/05/2025 Ascendis Pharma A/S (NASDAQ:ASND) Capital Efficiency Analysis
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.